 |

Transmission of Human Papillomavirus in Heterosexual Couples CME DisclosuresRelease Date: May 14, 2008; Valid for credit through May 14, 2009 | | Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians |  | 
| Contents of This CME Activity |  |
 | To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.
Transmission of Human Papillomavirus in Heterosexual Couples Brenda Y. Hernandez, PhD, MPH Lynne R. Wilkens, DrPH Xuemei Zhu, MD Pamela Thompson, MPH Katharine McDuffie, BS Yurii B. Shvetsov, PhD Lori E. Kamemoto, MD, MPH Jeffrey Killeen, MD Lily Ning, MD Marc T. Goodman, PhD, MPH
Go to Test Questions |
| Legal Disclaimer |  |
 | The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
 |


|



Learning Objectives Upon completion of this activity, participants will be able to: - Identify the most common baseline human papillomavirus (HPV) status of couples
- Specify the most common mode of transmission of HPV between couples
- Describe the role of anatomic sites in the transmission of HPV
- Identify behavioral factors associated with the transmission of HPV
Authors and Disclosures Brenda Y. Hernandez, PhD, MPH Disclosure: Brenda Y. Hernandez, PhD, MPH, has disclosed no relevant financial relationships. Lynne R. Wilkens, DrPH Disclosure: Lynne R. Wilkens,
DrPH, has disclosed no relevant financial relationships. Xuemei Zhu, MD Disclosure: Xuemei Zhu, MD, has disclosed no relevant financial relationships. Pamela Thompson, MPH Disclosure: Pamela Thompson, MPH, has disclosed no relevant financial relationships. Katharine McDuffie, BS Disclosure:
Katharine McDuffie, BS, has disclosed no relevant financial relationships. Yurii B. Shvetsov, PhD Disclosure: Yurii B. Shvetsov, PhD, has disclosed no relevant financial relationships. Lori E. Kamemoto, MD, MPH Disclosure: Lori E. Kamemoto, MD, MPH, has disclosed that she has received grants for clinical research from GlaxoSmithKline, and is on the
speaker's bureau for Merck. Jeffrey Killeen, MD Disclosure: Jeffrey Killeen, MD, has disclosed no relevant financial relationships. Lily Ning, MD Disclosure: Lily Ning, MD, has disclosed no relevant financial relationships. Marc T. Goodman, PhD, MPH Disclosure: Marc T. Goodman, PhD, MPH,
has disclosed no relevant financial relationships. Charles P. Vega, MD Disclosure: Charles P. Vega, MD, has disclosed that he has served as an advisor or consultant to Novartis, Inc. D. Peter Drotman, MD Disclosure: D. Peter Drotman, MD, has disclosed no relevant financial relationships.
|
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
 |